BS01 in Patients With Retinitis Pigmentosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Retinitis Pigmentosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

New Jersey Retina, Teaneck, New Jersey, United States
Contact: Study coordinator (Lauryn Onkendi) · lonkendi@njretina.com · (201)837-7300
Contact: Principal Investigator (Paul Hahn, MD)

Study leads

Sheila Nirenberg, PhD
Study Director
Bionic Sight LLC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Primary Photoreceptor Disease · Retinitis Pigmentosa (RP) · Usher Syndrome

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Miami, United States

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

Retinitis Pigmentosa

Abroad (travel likely)RecruitingPHASE2

Sydney, Australia · Woolloongabba, Australia

A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

Retinitis Pigmentosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States · Minneapolis, United States

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Retinitis Pigmentosa

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Bakersfield, United States